Inactive Instrument

Insiders GTx, Inc. Nasdaq

Equities

Oncternal Therapeutics, Inc. Appoints Damien Bresson as Senior Director, Preclinical and Translation Science	01/02	CI
Oncternal Therapeutics, Inc. Adds Matthew Smith to its Prostate Cancer Scientific Advisory Board	25/23/25	CI
Oncternal Therapeutics, Inc. Announces Resignation of Gunnar Kaufmann as Chief Scientific Officer, Effective June 14, 2023	03/23/03	CI
Oncternal Therapeutics, Inc. Appoints Jill DeSimone to the Board of Directors	05/23/05	CI
Oncternal Therapeutics, Inc. Announces the Resignation of Jinzhu Chen from the Board of Directors	24/22/24	CI
Oncternal Therapeutics, Inc. Announces Board Appointments	03/21/03	CI
Oncternal Therapeutics, Inc. Appoints Pablo Urbaneja as Senior Vice President, Corporate Development	02/21/02	CI
Oncternal Therapeutics, Inc. Elects Jinzhu Chen as Class II Director	29/21/29	CI
Oncternal Therapeutics, Inc. Announces Appointment of Salim Yazji as Chief Medical Officer	18/21/18	CI
Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel	13/21/13	CI
Oncternal Therapeutics, Inc. Appoints Rosemary Mazanet as a Class I Director	29/21/29	CI
Hazel M. Aker Intends to Retire as General Counsel of Oncternal Therapeutics, Inc., Effective August 15, 2020	01/20/01	CI
Oncternal Therapeutics, Inc. Announces Board Changes	23/19/23	CI
Oncternal Therapeutics, Inc. Announces Executive Appointments	09/19/09	CI
Oncternal Therapeutics, Inc. Announces Management Appointments	29/19/29	CI
Oncternal Therapeutics, Inc. Announces Additions to the Board of Directors	03/18/03	CI

No results for this search